# Study on the Effect of Influenza Vaccination After Heart Attack on Future Cardiovascular Prognosis

Study · id `cardio:ct-nct02831608` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02831608](<https://clinicaltrials.gov/study/NCT02831608>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02831608

Browse, organ or system: Heart; Brain  
Browse, condition area: Coronary and vascular disease; Stroke; Heart failure; Acute care and long-term living  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 2571 participants.

## Technical summary

Registry record NCT02831608. Randomized; quadruple masking; primary purpose treatment. Start 2016-10 (registry gives no type); primary completion 2021-04 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 2571 participants (enrolled count; ClinicalTrials.gov record NCT02831608, source copy `cardio:ctgov-nct02831608-2021-09-22`, retrieved 2026-10-26)
- Start date: 2016-10 (registry gives no type) (ClinicalTrials.gov record NCT02831608, source copy `cardio:ctgov-nct02831608-2021-09-22`, retrieved 2026-10-26)
- Primary completion: 2021-04 (actual) (ClinicalTrials.gov record NCT02831608, source copy `cardio:ctgov-nct02831608-2021-09-22`, retrieved 2026-10-26)
- Completion: 2021-08 (actual) (ClinicalTrials.gov record NCT02831608, source copy `cardio:ctgov-nct02831608-2021-09-22`, retrieved 2026-10-26)
- Countries: Australia; Bangladesh; Czechia; Denmark; Latvia; Norway; Sweden; United Kingdom (ClinicalTrials.gov record NCT02831608, source copy `cardio:ctgov-nct02831608-2021-09-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02831608-2021-09-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Study on the Effect of Influenza Vaccination After Heart Attack on Future Cardiovascular Prognosis
- Acronym: IAMI
- Condition: Myocardial Infarction
- Condition: Influenza, Human
- Condition: Influenza Vaccines
- Condition: Heart Failure
- Condition: Stroke
- Intervention (Biological): Influenza vaccine
- Intervention (Biological): Placebo
- Lead sponsor: Ole Frobert, MD, PhD
- Lead sponsor class: OTHER
- Collaborator: Swedish Heart Lung Foundation
- Collaborator class: OTHER
- Collaborator: Sanofi Pasteur, a Sanofi Company
- Collaborator class: INDUSTRY
- Collaborator: Uppsala University
- Collaborator class: OTHER
- Collaborator: Lytics
- Collaborator class: UNKNOWN

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as a collaborator: Swedish Heart Lung Foundation (`cardio:org-swedish-heart-lung-foundation`)
- Registry lists this organization as a collaborator: Uppsala University (`cardio:org-uppsala-university`)

### Main results

- Registry lists this paper as a reference of type result; PubMed types it as a trial report that names this trial and no other, dated on or after the trial start, and its title marks no secondary, follow-up or other further analysis: Influenza Vaccination After Myocardial Infarction: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial (`cardio:pubmed-34459211`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 8604a3e1228ce288cb0e4d04e286675ecbf488f76f4c7eaa0e3f869eabb89e4d
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
